Fellowship · Indianapolis, IN
Sponsored by Indiana University School of Medicine
Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network : JNCCN · 2024 · 922 citations · Greg Durm
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.
The New England journal of medicine · 2023 · 703 citations · Lisa Landrum
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.
The New England journal of medicine · 2023 · 633 citations · Lisa Landrum
NCCN Guidelines® Insights: Head and Neck Cancers, Version 2.2025.
Journal of the National Comprehensive Cancer Network : JNCCN · 2025 · 159 citations · Greg Durm
NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 2.2023.
Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 469 citations · Greg Durm
Management of Salivary Gland Malignancy: ASCO Guideline.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021 · 356 citations · Michael Moore
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial.
Nature medicine · 2021 · 558 citations · Jianjun Zhang
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology · 2022 · 385 citations · Jianjun Zhang